XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
At the Market Offering
COMMON STOCK
COMMON STOCK
At the Market Offering
ADDITIONAL PAID-IN CAPITAL
ADDITIONAL PAID-IN CAPITAL
At the Market Offering
ACCUMULATED DEFICIT
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Ending balance (in shares)     31,841,084        
Ending balance $ 332,213   $ 3   $ 713,636   $ (381,426)
Beginning balance (in shares) at Dec. 31, 2023     31,841,084        
Beginning balance at Dec. 31, 2023 332,213   $ 3   713,636   (381,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of underwriting discounts, commissions and offering costs (in shares)     4,025,000        
Issuance of common stock, net of underwriting discounts, commissions, and offering costs 151,057       151,057    
Exercise of common stock options (in shares)     201,702        
Exercise of common stock options 5,721       5,721    
Stock-based compensation 8,070       8,070    
Net income (loss) (43,114)           (43,114)
Beginning balance (in shares) at Dec. 31, 2023     31,841,084        
Beginning balance at Dec. 31, 2023 332,213   $ 3   713,636   (381,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (141,327)            
Ending balance (in shares)     36,067,786        
Ending balance 453,947   $ 3   878,484   (424,540)
Beginning balance (in shares) at Mar. 31, 2024     36,067,786        
Beginning balance at Mar. 31, 2024 453,947   $ 3   878,484   (424,540)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of underwriting discounts, commissions and offering costs (in shares)       14,068      
Issuance of common stock, net of underwriting discounts, commissions, and offering costs   $ 474       $ 474  
Exercise of common stock options (in shares)     87,704        
Exercise of common stock options 2,967       2,967    
Stock-based compensation 8,785       8,785    
Net income (loss) (45,257)           (45,257)
Ending balance (in shares)     36,169,558        
Ending balance 420,916   $ 3   890,710   (469,797)
Beginning balance (in shares) at Jun. 30, 2024     36,169,558        
Beginning balance at Jun. 30, 2024 420,916   $ 3   890,710   (469,797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of underwriting discounts, commissions and offering costs (in shares)       3,045,762      
Issuance of common stock, net of underwriting discounts, commissions, and offering costs   $ 155,050   $ 1   $ 155,049  
Exercise of common stock options (in shares)     43,156        
Exercise of common stock options 1,008       1,008    
Stock-based compensation 8,817       8,817    
Net income (loss) (52,956)           (52,956)
Ending balance (in shares)     39,258,476        
Ending balance 532,835   $ 4   1,055,584   (522,753)
Ending balance (in shares)     40,554,705        
Ending balance 571,553   $ 4   1,140,328   (568,779)
Beginning balance (in shares) at Dec. 31, 2024     40,554,705        
Beginning balance at Dec. 31, 2024 571,553   $ 4   1,140,328   (568,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     7,342        
Exercise of common stock options 4       4    
Stock-based compensation 8,863       8,863    
Net income (loss) 148,451           148,451
Beginning balance (in shares) at Dec. 31, 2024     40,554,705        
Beginning balance at Dec. 31, 2024 $ 571,553   $ 4   1,140,328   (568,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares) 65,653            
Net income (loss) $ 110,475            
Ending balance (in shares)     40,562,047        
Ending balance 728,871   $ 4   1,149,195   (420,328)
Beginning balance (in shares) at Mar. 31, 2025     40,562,047        
Beginning balance at Mar. 31, 2025 728,871   $ 4   1,149,195   (420,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     53,367        
Exercise of common stock options 17       17    
Stock-based compensation 8,542       8,542    
Net income (loss) (30,696)           (30,696)
Ending balance (in shares)     40,615,414        
Ending balance 706,734   $ 4   1,157,754   (451,024)
Beginning balance (in shares) at Jun. 30, 2025     40,615,414        
Beginning balance at Jun. 30, 2025 706,734   $ 4   1,157,754   (451,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common shares under employee stock purchase plan (in shares)     11,806        
Issuance of common shares under employee stock purchase plan 138       138    
Exercise of common stock options (in shares)     4,944        
Exercise of common stock options 2       2    
Stock-based compensation 3,986       3,986    
Net income (loss) (7,280)           (7,280)
Ending balance (in shares)     40,632,164        
Ending balance $ 703,580   $ 4   $ 1,161,880   $ (458,304)